![Creatine-Kinase- and Exercise-Related Muscle Damage Implications for Muscle Performance and Recovery Creatine-Kinase- and Exercise-Related Muscle Damage Implications for Muscle Performance and Recovery](https://static-01.hindawi.com/articles/jnme/volume-2012/960363/figures/960363.fig.001.jpg)
Creatine-Kinase- and Exercise-Related Muscle Damage Implications for Muscle Performance and Recovery
![PDF] Relevance of macro creatine kinase type 1 and type 2 isoenzymes to laboratory and clinical data. | Semantic Scholar PDF] Relevance of macro creatine kinase type 1 and type 2 isoenzymes to laboratory and clinical data. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d9200dac0c4bd071155d0e1bcb9080d7dcbbc4cd/2-Table1-1.png)
PDF] Relevance of macro creatine kinase type 1 and type 2 isoenzymes to laboratory and clinical data. | Semantic Scholar
![PDF) Anomalous Activity Measurements of Creatine (Phospho) Kinase, CK-MB Isoenzyme in Indian Patients in the Diagnosis of Acute Coronary Syndrome PDF) Anomalous Activity Measurements of Creatine (Phospho) Kinase, CK-MB Isoenzyme in Indian Patients in the Diagnosis of Acute Coronary Syndrome](https://i1.rgstatic.net/publication/51974307_Anomalous_Activity_Measurements_of_Creatine_Phospho_Kinase_CK-MB_Isoenzyme_in_Indian_Patients_in_the_Diagnosis_of_Acute_Coronary_Syndrome/links/54b7966d0cf2bd04be33a8a7/largepreview.png)
PDF) Anomalous Activity Measurements of Creatine (Phospho) Kinase, CK-MB Isoenzyme in Indian Patients in the Diagnosis of Acute Coronary Syndrome
![PDF] Relevance of macro creatine kinase type 1 and type 2 isoenzymes to laboratory and clinical data. | Semantic Scholar PDF] Relevance of macro creatine kinase type 1 and type 2 isoenzymes to laboratory and clinical data. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d9200dac0c4bd071155d0e1bcb9080d7dcbbc4cd/3-Figure2-1.png)
PDF] Relevance of macro creatine kinase type 1 and type 2 isoenzymes to laboratory and clinical data. | Semantic Scholar
![Sample/practice exam 13 February 2021, questions and answers - Miayo, Hersey C. CCHM322@LAB Critical - StuDocu Sample/practice exam 13 February 2021, questions and answers - Miayo, Hersey C. CCHM322@LAB Critical - StuDocu](https://d20ohkaloyme4g.cloudfront.net/img/document_thumbnails/cbf582fc4b27fe4b0370ca8de98e1dcd/thumb_1200_1553.png)
Sample/practice exam 13 February 2021, questions and answers - Miayo, Hersey C. CCHM322@LAB Critical - StuDocu
![Macrocreatincinasa tipo 1 como causa de aumento de la isoenzima CK-MB. A propósito de 7 casos | Semantic Scholar Macrocreatincinasa tipo 1 como causa de aumento de la isoenzima CK-MB. A propósito de 7 casos | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/0b7c63255fd3cc86dea329f5008a0cc4a2d96c5c/4-Figure1-1.png)
Macrocreatincinasa tipo 1 como causa de aumento de la isoenzima CK-MB. A propósito de 7 casos | Semantic Scholar
![An unusual interference in CK MB assay caused by a macro enzyme creatine phosphokinase (CK) type 2 in HIV-infected patients An unusual interference in CK MB assay caused by a macro enzyme creatine phosphokinase (CK) type 2 in HIV-infected patients](https://www.degruyter.com/document/doi/10.1515/cclm-2012-0404/asset/graphic/j_cclm-2012-0404_fig_001.jpg)
An unusual interference in CK MB assay caused by a macro enzyme creatine phosphokinase (CK) type 2 in HIV-infected patients
![Creatine-Kinase- and Exercise-Related Muscle Damage Implications for Muscle Performance and Recovery Creatine-Kinase- and Exercise-Related Muscle Damage Implications for Muscle Performance and Recovery](https://static-01.hindawi.com/articles/jnme/volume-2012/960363/figures/960363.fig.003b.jpg)
Creatine-Kinase- and Exercise-Related Muscle Damage Implications for Muscle Performance and Recovery
![Figure 1 from Relevance of macro creatine kinase type 1 and type 2 isoenzymes to laboratory and clinical data. | Semantic Scholar Figure 1 from Relevance of macro creatine kinase type 1 and type 2 isoenzymes to laboratory and clinical data. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d9200dac0c4bd071155d0e1bcb9080d7dcbbc4cd/1-Figure1-1.png)